• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    IO Biotech, Inc. - Common Stock (NQ: IOBT )

    1.270 -0.050 (-3.79%)
    Streaming Delayed Price Updated: 3:59 PM EDT, May 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 68,394
    Open 1.330
    Bid (Size) 1.250 (2)
    Ask (Size) 1.450 (3)
    Prev. Close 1.320
    Today's Range 1.250 - 1.350
    52wk Range 0.8163 - 2.200
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    IOBT Stock Earnings: IO Biotech Beats EPS for Q1 2024
    IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -33.51%
    -33.51%
    1 Month
    -13.01%
    -13.01%
    3 Month
    -15.89%
    -15.89%
    6 Month
    +8.55%
    +8.55%
    1 Year
    -38.05%
    -38.05%

    More News

    Read More
    IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023
    Via InvestorPlace
    Top 5 Health Care Stocks That May Crash This Month
    Via Benzinga
    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IO Biotech: Q3 Earnings Insights
    Via Benzinga
    IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
    Via ACCESSWIRE
    Expert Ratings for IO Biotech
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
    Via Benzinga
    Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Why Are IO Biotech Shares Trading Lower Today
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Heritage Insurance And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.